These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Plasma exchange in anti-glomerular basement membrane disease. Prendecki M; Pusey C Presse Med; 2019 Nov; 48(11 Pt 2):328-337. PubMed ID: 31703956 [TBL] [Abstract][Full Text] [Related]
8. Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease. Ohlsson S; Herlitz H; Lundberg S; Selga D; Mölne J; Wieslander J; Segelmark M Am J Kidney Dis; 2014 Feb; 63(2):289-93. PubMed ID: 24189476 [TBL] [Abstract][Full Text] [Related]
9. Goodpasture's disease: a report of ten cases and a review of the literature. Dammacco F; Battaglia S; Gesualdo L; Racanelli V Autoimmun Rev; 2013 Sep; 12(11):1101-8. PubMed ID: 23806563 [TBL] [Abstract][Full Text] [Related]
10. Anti-glomerular basement membrane disease in children: a brief overview. Dowsett T; Oni L Pediatr Nephrol; 2022 Aug; 37(8):1713-1719. PubMed ID: 34767075 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience. Zahir Z; Wani AS; Prasad N; Jain M Ren Fail; 2021 Dec; 43(1):79-89. PubMed ID: 33334228 [TBL] [Abstract][Full Text] [Related]
12. Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis. Borza DB Nephron Exp Nephrol; 2007; 106(2):e37-43. PubMed ID: 17570938 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and classification of Goodpasture's disease (anti-GBM). Hellmark T; Segelmark M J Autoimmun; 2014; 48-49():108-12. PubMed ID: 24456936 [TBL] [Abstract][Full Text] [Related]
15. Recurrence of Goodpasture syndrome without circulating anti-glomerular basement membrane antibodies after kidney transplant, a case report. Thibaud V; Rioux-Leclercq N; Vigneau C; Morice S BMC Nephrol; 2019 Jan; 20(1):6. PubMed ID: 30621605 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection and recurrence of anti-glomerular basement disease: a case report. Winkler A; Zitt E; Sprenger-Mähr H; Soleiman A; Cejna M; Lhotta K BMC Nephrol; 2021 Feb; 22(1):75. PubMed ID: 33639869 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and management challenges in Goodpasture's (anti-glomerular basement membrane) disease. Henderson SR; Salama AD Nephrol Dial Transplant; 2018 Feb; 33(2):196-202. PubMed ID: 28459999 [TBL] [Abstract][Full Text] [Related]
18. Atypical Goodpasture's disease: a clinical case report and literature review. Bulanova ML; Potapov DV; Bulanov NM; Lysenko Kozlovskaya LV Ter Arkh; 2018 Jun; 90(6):130-136. PubMed ID: 30701916 [TBL] [Abstract][Full Text] [Related]
19. [Goodpasture disease]. Fomegné G; Dratwa M; Wens R; Mesquita M; Van der Straaten M; Vanden Haute K; Fosso C Rev Med Brux; 2006; 27(3):162-6. PubMed ID: 16894954 [TBL] [Abstract][Full Text] [Related]
20. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease. Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]